throbber
Trials@uspto.gov
`Tel: 571-272-7822
`
`Paper 80
`Entered: June 21, 2021
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`PFIZER
`
`INC.,!
`Petitioner,
`
`V.
`
`NOVO NORDISK A/S,
`Patent Owner.
`
`IPR2020-003247
`Patent 8,114,833 B2
`
`  ÿÿ
`ÿ
`  
`

` ÿ
`  ÿÿÿÿ
`ÿ
`ÿÿ
`ÿ
`ÿÿ
`
` !"ÿ#$#ÿ$ ÿ$ "ÿ%$"&$%'ÿ())!*ÿ
`++++++++++++ÿ
`ÿ
`,)(%ÿ-ÿ$ ÿ%!$.ÿ$ "ÿ$$.ÿ,($%"ÿ
`++++++++++++ÿÿ
`)!/%ÿ! * ÿ
`  
` ÿÿ ÿÿ
` (0(ÿ (%"!#'ÿ$1#ÿ
`  ÿ(2 ÿ
`++++++++++++ÿ
`ÿ
`!%34ÿ
`  ÿ433ÿ,ÿ
`++++++++++++ÿ
`ÿ
`ÿ,5
` ÿ%!*$ÿ$ ÿ)%$ '.! ÿ(- ÿ6 ÿ 7ÿ ÿÿ
`##$ ÿ. ÿ* ÿ&!*-..ÿ89:;<;=>?@>;ABÿD@>B<>ÿEF9GB=Hÿ
`ÿ)%$ '.! ÿ89:;<;=>?@>;ABÿD@>B<>ÿEF9GB ÿ
`ÿÿ
`(%"%ÿ
`6  
ÿ
` ÿ&
` 
`ÿ
`ÿ I ÿ Jÿ
`K
ÿ ÿ
` ÿ%L ÿ
`ÿ
`  ÿ# I ÿ"
`KI ÿ ÿ,ÿ*
`5  ÿ!5
` I 
`ÿÿ
`MNÿOHPHQÿRÿMSTÿ
`ÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿ
`ÿJÿ
`K
ÿJ ÿUÿ  I ÿ ÿ
`ÿ Jÿ
` 
 ÿ  
` ÿ&V ÿ
`!   
` ÿ..* ÿÿ  ÿW ÿ
`ÿ!%ÿJ ÿUÿX
`ÿ2 Jÿ Jÿ
`K
ÿÿ  ÿ33 ÿ
`
`ORDER
`Joint Motion to Terminate the
`and Joint Request
`Proceeding
`Granting
`Treat Settlement Documents as Business Confidential Information
`35 U.S.C $ 317
`
`Before ERICA A. FRANKLIN, JOHN G. NEW,and
`SUSANL. C. MITCHELL, Administrative Patent
`Judges.
`
`FRANKLIN,Administrative Patent
`
`Judge.
`
`to
`
`'
`
`This proceeding has been terminated asto the original petitioner, Mylan
`Institutional LLC. Paper 67.
`2
`IPR2020-01252 has been joined with this proceeding. Paper 33.
`
`

`

`IPR2020-00324
`Patent 8,114,833 B2
`
`With authorization of the Board, Novo Nordisk A/S
`(“Patent Owner”)
`filed a
`motion to terminate the
`and Pfizer Inc.
`
`(“Petitioner Pfizer’’)
`joint
`77. Patent Ownerfiled a true copy
`
`proceeding. Paper
`settlement agreement under seal. Ex. 2102.
`filed a
`
`oftheir written
`
`with authorization
`
`was
`
`proceeding
`
`Mylan
`
`Mylan
`
`because
`
`they
`
`agreementthat settled their
`
`andall
`
`between
`
`joint
`reached an
`
`them
`
`involving
`we
`
`Additionally,
`joint request that the settlement agreement
`from the Board, the
`parties
`be treated as business confidential information and
`kept separate from the
`file of US Patent No. 8,114,833 B2
`(Ex. 1001, “the ’833
`patent”). Paper 78.
`The Decision on Institution for this
`was entered on June
`proceeding
`23, 2020. Paper 12. The Decision on Institution of IPR2020-01252 and
`Petitioner Pfizer Inc.’s Motion for Joinder with this
`Granting
`proceeding
`entered on December4, 2020. Paper 33. On March 26, 2021, the
`parties
`at an oral
`hearing. Paper 51. Thereafter, with
`presented arguments
`filed a
`authorization from the Board, Patent Ownerand Petitioner
`as to Petitioner
`motion to terminate the
`
`    ÿÿ
`
`

`ÿ  ÿ ÿ
`ÿ
`
`ÿ 
`
`
ÿÿ
` ÿ ÿÿÿ ÿ!"
`

`ÿ#$
%&ÿ
`
ÿ  ÿ
'(ÿ!"
`
`
ÿ  %&ÿ) ÿ ÿ*

`ÿ+
`
ÿ
`ÿ
` +

` ÿ
` ÿ
`,' 
-(ÿÿ , ÿ..(ÿÿ
`

`ÿ#$
ÿ) ÿ ÿ
` ÿ',/ÿÿ
` ÿ$
`
`
ÿ
`
`
`) +

`ÿ - +

`ÿ
 ÿ )(ÿÿ01(ÿ  (ÿÿ
`
))/ÿ$
`ÿ 
`
`
ÿ
`+ÿ
` ÿ ÿ
` ÿ, 
` ÿ) ÿ ÿ*

`ÿ 2 
`ÿ
`
`ÿ
` ÿ
`
`) +

`ÿ - +

`ÿ
`3 ÿ
`
` ÿ ÿ3
ÿ'


` )ÿ
+
`
ÿ
ÿ ,
`ÿ , 
` ÿ+ÿ
` ÿ
`) ÿÿ4 ÿ
`

`ÿ(ÿ  ÿ ÿ!01(ÿÿ"
` ÿ5 ÿ,
`

`%&(ÿÿ , ÿ. (ÿÿÿ
`6 ÿ7 '
ÿ
ÿ

`
`
`
ÿÿ
`ÿ,' 
-ÿ$ ÿ

`  ÿ
ÿ8
ÿ
` ÿ  (ÿÿ , ÿ (ÿÿ6 ÿ7 '
ÿ
ÿ

`
`
`
ÿÿ    9 ÿ
ÿ
`:

`
-ÿ
`
`
ÿ  ÿ
'(5ÿ;
`
ÿÿ8
 ÿ$
`ÿ
`ÿ,' 
-ÿ$ ÿ
`

`  ÿ
ÿ7 ' +3 ÿÿ  (ÿÿ , ÿ(ÿÿ#
ÿ; 'ÿ <ÿ  ÿ
` ÿ, 
` ÿ
`, 

` ÿ -+

`ÿ
`ÿ
ÿ )ÿ 
-(ÿÿ , ÿ9(ÿÿ6  
` ÿ$
`ÿ
` 
`
`
ÿ+ÿ
` ÿ ÿ
`

`ÿ#$
ÿ
ÿ
`
`
ÿ;/)
ÿ) ÿ ÿ
`*

`ÿ+
`
ÿ
`ÿ
` +

` ÿ
` ÿ,' 
-ÿ ÿ
`ÿ
`
`
ÿ;/)
ÿ3 '  ÿ
` /ÿ
` ' ÿ
ÿ - +

`ÿ
`
`ÿ
`
`) ÿ
` ÿ,
` ÿ
ÿ ))ÿ)
`-
`
ÿ3
`$
ÿ
`
` +ÿ
)
-ÿ
` ÿ5 ÿ,
`

`(ÿÿ , ÿ<<ÿ=<(ÿÿÿ

` ÿ
ÿ
`

` ÿÿ
` 3 ÿ$ ÿ-

` ÿ
` ÿ6 +

`
ÿ ÿ
`ÿ
`
`
ÿ;/)
ÿ
ÿ,)ÿ<ÿ  (ÿÿ
` , ÿ<.(ÿÿ#
ÿ
`
`ÿ + ÿ
` ÿ
`
`
ÿ  ÿ
ÿ
`

`ÿ#$
ÿ 2 
` ÿ
` 
`
`
ÿ
`ÿ) ÿ ÿ+
`
ÿ
`ÿ
` +

` ÿ
` ÿ,' 
-(ÿÿ ÿ
$ÿ'
 ÿ
`
`
`ÿ+
`
ÿ ÿ$ ))ÿ ÿ
` ÿ*

`ÿ 2 
`ÿ
`ÿ
`
`ÿ
` ÿ
`
`) +

`ÿ - +

`ÿ
` ÿ3
ÿ'


` )ÿ
+
`
ÿ
ÿ
`ÿ ,ÿ
`ÿ , 
` ÿ+ÿ
` ÿ) ÿÿ
`
` ÿ5 ÿ,
`

`(ÿÿÿ
` ÿ
`
`dispute
`litigation
`the ’833 patent. Paper 66, 1-6. As noted in footnote 1,
`on
`the Termination as to Petitioner
`April 16, 2021.
`above,
`Mylan
`granted
`Paper 67. On that same
`date, Petitioner Pfizer and Patent Owner
`requested
`authorization to file a motion to terminate the
`We now consider
`
`proceeding.
`to treat their settlement agreement
`that motion,
`joint request
`as business confidential information and to
`
`as well as their
`
`the ’833 patent.
`
`keep
`
`it separate from thefile of
`
`

`

`dispute concerning
`they
`to moveto terminate this
`
`agreed
`
`Ex.
`
`The
`
`proceeding
`that there is no
`
`(citing
`district court
`
`appropriate
`the ’833 patent and have
`in full. Mot. 2
`
`IPR2020-00324
`Patent 8,114,833 B2
`
`The
`
`parties
`
`assert that their
`
`requested
`
`because
`
`havesettled their
`
`termination is
`
`    ÿÿ
`
`

`ÿ  ÿ ÿ
`ÿ
`ÿ ÿ 
` ÿ  
`ÿ
`
`ÿ
` ÿ  
` ÿ
` 

`
ÿÿ 
` ÿ
`   ÿ
` ÿ  ÿ
`
` ÿ
` ÿ
` ÿ
 

!ÿ
` ÿ" ÿ
`

`ÿ
ÿ  ÿ
` ! ÿ
`ÿ ÿ
`ÿ
` 

` ÿ
`ÿ 
!ÿ
ÿ# $ÿÿ%
`$ÿ ÿ&
`
!ÿ
`'($ÿ  )$ÿÿ ÿ 
` ÿ ( 
ÿ
`
`ÿ
`  ÿÿ
ÿ

!ÿ
`
`ÿ
`ÿ
` 
`!
`
ÿ
`*
ÿ
` ÿ
`
`ÿ
  ÿ
` ÿ" ÿ
`

`$ÿÿ+,-ÿ
`ÿ$ÿÿ.
`
ÿ
`
` ÿ 
` ÿ
#ÿ
`
`ÿ
` ÿ
`
`ÿ
`ÿ 
`!
`
ÿ
`*
ÿ
`

`ÿ/*
ÿ
`
ÿ%
ÿ
 
!ÿ
` ÿ" ÿ
`

`ÿ$ $ÿ0121ÿ014,567ÿ+89-ÿ:;ÿ<=-ÿ2-ÿ>?=<8ÿ
`+86;5;@;518<=ÿAABÿC$.$ÿD$ÿEFFÿ&G$ÿG $)ÿ* ÿ   ÿÿ ÿ
`
`
` 

`ÿ
`*
ÿ
` ÿ 
` ÿ
ÿ ÿÿ
` ÿ
`ÿ
ÿ. ÿHÿ
`  $ÿÿ+,-ÿÿI
` ÿ
` ÿ 
` ÿ 
` ÿ

` ÿ
`
`ÿ
` ÿ ÿ ÿ

`ÿ ÿ ÿ
`#
ÿ*
`
`
ÿ 
ÿ
ÿ
`ÿ 
!$ÿÿ+,-ÿÿÿ
`J 
!ÿ
  ÿ
` ÿ
`
 ÿ
  ÿ
ÿ
`ÿ 
!ÿ
`
 
!ÿ
` ÿ# !
!ÿ  
`
ÿ#ÿ
` ÿ 
` ÿ* ÿ
` 
ÿ
`
`ÿ ÿ
`
` 

`
ÿ#ÿ
` ÿ 
!ÿÿ 
` $ÿÿÿ
`K
 ÿFÿK$L$C$ÿMÿN&)ÿÿ
`O P
ÿ ! 

`ÿÿ
 
`

!ÿ
`*
ÿ
` ÿ
`

`ÿ*
ÿ
ÿ
` ÿ
`
`
ÿ
 
!ÿ
ÿ
`  ÿ ! 

`ÿ #  ÿ
`ÿ
ÿ
`ÿ ! 

`ÿÿ
 
`

!ÿ  ÿ
ÿ

`
ÿ*
`ÿÿ
ÿ
`

` 
`
ÿ#ÿ
` ÿ
` 

`
ÿ#ÿ
ÿ

` ÿ 
` ÿ  *ÿ
 ÿ
`
`ÿ 
`
ÿ ÿ ÿ
ÿ*
`
!ÿ
ÿ ÿ
` ÿÿ#ÿÿ ! 

`ÿ
`ÿ
 
`

!ÿ ÿ ÿ# ÿ
ÿ
` ÿ/## ÿ # ÿ
` ÿ
`
` 

`
ÿ#ÿ
` ÿ

` ÿ 
` ÿ  *ÿ ÿ
`*
ÿ
` ÿ 
` $ÿ
`ÿQ::ÿ<=61ÿNÿC$I$$ÿMÿ $N&)ÿ&R.
ÿ ! 

`ÿÿ
 
`

!ÿ
`*
ÿ
`
` ÿ 
` ÿ  ÿ
ÿ

`
ÿ*
`ÿÿ
ÿ

` 
`
ÿ#ÿ
` ÿ
` 

`
ÿ
`#ÿ ÿ 
!ÿ ÿ ÿ
ÿ*
`
!ÿ
ÿ ÿ
` ÿÿ ÿ ÿ# ÿ*
`ÿ
` ÿ
` ÿ # ÿ
` ÿ
` 

`
ÿ#ÿ
` ÿ
` $S)$ÿÿ.ÿ

` ÿ  ÿ
` ÿ 
` ÿ# ÿ
` ÿ
`
` 

`ÿ ! 

`ÿ
`
!ÿ
`ÿ
`  ÿ 
!$ÿÿ
ÿ
` ÿT

`ÿ
`
ÿ
`
` ÿ 
`#ÿ
`
`ÿR'(
`ÿ  ÿÿ ÿ
` ÿ
ÿ
` ÿÿ#ÿ
` ÿL
`
` 

`ÿ
`ÿ
`
`proceeding
`appropriate.
`Under35 U.S.C. § 317(b),
`or
`owner and
`between the patent
`[a]ny agreement
`understanding
`a
`petitioner, including any collateral agreements referred to in
`or
`made in connection with,or in
`such agreement
`understanding,
`contemplation of, the termination of an inter partes review under
`and a true copy of such agreement
`this section shall be in
`writing
`or
`shall be filed in the Office before the
`understanding
`termination ofthe inter partes review as between the
`
`2102).
`parties explain
`pending
`between them that involves the ’833 patent. Jd. at3.
`confirm that the district court
`between Patent Owner
`litigation
`the ’833 patent, 1.e., Novo Nordisk Inc. et al. v.
`Mylan involving
`was resolved
`Institutional LLC, C.A. No. 19-cv-01551
`
`litigation
`
`parties
`
`the
`
`and
`
`settlement between those
`
`parties
`
`(D. Del.),
`the court on
`
`and dismissed
`
`Additionally,
`
`Mylan
`a
`
`by
`
`April 6,
`by
`note that the Board has not issued a
`
`2021. Jd. Further, the
`
`parties correctly
`
`final written decision in this
`
`proceeding.
`
`Jd.
`
`Having
`
`considered the circumstances involvedin this
`
`proceeding,
`we determine that a
`
`including
`
`the
`
`foregoing
`
`assertions of the
`
`parties,
`
`termination of the
`
`is
`
`parties.
`
`See also 37 C.F.R. § 42.74(b) (“Any agreementor
`understanding
`or in
`made in connection with,
`the
`contemplation of, the termination
`and a true copyshall
`be filed with the
`As noted above, the
`In their
`
`writing
`proceeding
`Board before the termination ofthe
`a settlement agreement relating
`joint motion,
`proceedings.
`that “Exhibit 2102 is a true and
`complete copy of the Settlement
`
`parties
`of a
`
`shall be in
`
`trial.”).
`to these
`
`they certify
`
`3
`
`between
`
`parties
`
`filed
`
`

`

`In accordance with the
`
`ORDEREDthat the
`
`joint
`
`it is
`
`foregoing,
`hereby:
`motion to terminate the
`
`proceeding
`
`is
`
`granted;
`FURTHER ORDEREDthatthis inter partes review is terminated;
`
`and
`
`FURTHER ORDEREDthatthe
`
`joint request that the settlement
`agreement, Ex. 2102, be treated as business confidential information and
`kept separate from the file of the ’833 patent is
`
`granted.
`
`IPR2020-00324
`Patent 8,114,833 B2
`
`Agreement, and there are no other written or oral agreements
`between Pfizer and Novo Nordisk that are made in
`
`or
`
`proceeding.”
`
`parties
`
`317(b).
`
`ORDER
`
`understandings
`or in
`contemplation of, the termination of the instant
`connection with,
`we determinethat the
`Mot. 2. Based on that understanding,
`havesatisfied section
`
`    ÿÿ
`
`

`ÿ  ÿ ÿ
`ÿ
` 

`ÿ
ÿ
`  ÿ  ÿ
ÿ
` ÿ
`
`
ÿÿ ÿ  

`ÿÿ
`
 
`

ÿ
`
ÿ  ÿ
ÿ !ÿ "ÿ
`
`ÿ  ÿ  ÿ
ÿ
`#
#
`
ÿ
`ÿÿ
ÿ#

` $
`
ÿÿ
` ÿ
` 

`
ÿÿ
` ÿ

`

`ÿ
`$# 
%&ÿÿ'
`%ÿ %ÿÿ  ÿ
ÿ
`
`ÿ
 
`

ÿ ÿ
` 
ÿ
`
`ÿ
` ÿ
`$ 
` ÿ ! ÿ
` ÿ #
`
ÿ()*%ÿÿÿÿ
`ÿ
`,-.ÿ
`ÿ
ÿ ##
# ÿ
`ÿ
` ÿ 
ÿ
`ÿÿ  /0ÿ
`,-..-ÿ
`
`ÿ
` ÿ1

`ÿ
`
ÿ
`ÿ
` 

` ÿ
` ÿ$# 
ÿÿ
`23456789ÿÿ:;<=.ÿ,-..-ÿ
`
`ÿ
`ÿ>5673ÿ?4367@ÿ ! ÿÿ673A>546789ÿ
`
ÿÿ:;<=.ÿ,-..-ÿ
`
`ÿ
` ÿ1

`ÿ B 
`ÿ
`
`ÿ
` ÿ
`
` 

`ÿ
`  

`ÿ.C%ÿ  ÿ ÿ
`
` ÿ ÿ
ÿ#


` ÿ

`
ÿ
ÿ
`" $
`ÿ $ 
` ÿÿ
` ÿ ÿÿ
` ÿD ÿ$
`

`ÿÿ2345678%ÿ
`ÿÿ
`ÿ
`ÿ
`
`

`

`IPR2020-00324
`Patent 8,114,833 B2
`
`For PETITIONER PFIZER INC:
`
`Thomas J. Meloro
`
`tmeloro@willkie.com
`
`Michael W. Johnson
`
`mjohnson1 @willkie.com
`
`    ÿÿ
`
`

`ÿ  ÿ ÿ
`ÿ
`ÿ ÿ ÿÿ
`ÿ ÿ ÿ! "ÿ
`
`
` "#$%""&% 'ÿ
`ÿ!%' "ÿ( ÿ

ÿ
`
`)

#$%""&% 'ÿ
`ÿÿ *ÿ(ÿ+ÿ,-.ÿ*/-ÿ
`ÿ 00 1ÿ "& ÿ
`) "& #0
$%'& 'ÿ
`ÿ1
ÿ

ÿ
`1
)

#0
$%'& 'ÿ
`ÿ2 3 ÿ!
ÿ
`2 3 
#0
$%'& 'ÿ
`
`Ryan Johnson
`Ryan.johnson@fenwick.com
`
`For PATENT OWNER NOVO NORDISKA/S:
`
`Oelke
`
`Jeffrey
`joelke@fenwick.com
`
`Laura Moran
`
`Laura.moran@fenwick.com
`
`ÿ
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket